首页> 外文期刊>EXCLI Journal >Review article - Why we do what we do. A brief analysis of cancer therapies
【24h】

Review article - Why we do what we do. A brief analysis of cancer therapies

机译:审查文章 - 为什么我们这样做。浅析癌症疗法

获取原文
           

摘要

The goal of all medical activity is to preserve health in fit people, and to restore the sick into a state of complete physical, mental and social wellbeing. In an effort to determine whether we are achieving this last goal in oncology, herein we review the biological and clinical framework that has led to the foundations of the current anticancer treatment paradigm. Currently, cancer therapy is still based on the ancient axiom that states that the complete eradication of the tumor burden is the only way to achieve a cure. This strategy has led to a substantial improvement in survival rates as cancer mortality rates have dropped in an unprecedented way. Despite this progress, more than 9 million people still die from cancer every year, indicating that the current treatment strategy is not leading to a cancer cure, but to a cancer remission, that is “the temporary absence of manifestations of a particular disease”; after months or years of remission, in most patients, cancer will inevitably recur. Our critical analysis indicates that it is time to discuss about the new key challenges and future directions in clinical oncology. We need to generate novel treatment strategies more suited to the current clinical reality.
机译:所有医疗活动的目标是保持健康人的健康,并将生病恢复为完全的身体,心理和社会福祉状态。努力确定我们是否在肿瘤学中达到这一目标,在此审查了导致目前抗癌治疗范式的基础的生物学和临床框架。目前,癌症疗法仍然基于古代公理,使得完全根除肿瘤负担是实现治愈的唯一方法。由于癌症死亡率以前所未有的方式降低,这种策略导致生存率的大量改善。尽管这一进展,每年超过900万人仍然死于癌症,表明目前的治疗策略并未导致癌症治愈,而是对癌症缓解,即“暂时没有特定疾病的表现形式”;经过数月或多年的缓解,在大多数患者中,癌症将不可避免地重复。我们的关键分析表明,是时候讨论了临床肿瘤学中的新关键挑战和未来方向的时候了。我们需要产生更适合目前临床现实的新型治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号